These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 9004814
1. [Secondary prevention of myocardial ischemia. From theory to clinical reality: preliminary results of the EUROASPIRE study in Italy. European Action on Secondary Prevention through Intervention to Reduce Events]. Ambrosio GB, Leprotti C, Vanuzzo D, Pilotto L, Pedrocco A, Perissinotto F, Stritoni P, Gallo A, Rossi L, Zardini P. Ann Ital Med Int; 1996 Oct; 11 Suppl 2():139S-142S. PubMed ID: 9004814 [Abstract] [Full Text] [Related]
2. Changes in secondary prevention of coronary artery disease in the post-discharge period over the decade 1997-2007. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and III surveys. Pajak A, Jankowski P, Kawecka-Jaszcz K, Surowiec S, Wolfshaut R, Loster M, Batko K, Badacz L, Dubiel JS, Grodecki J, Grodzicki T, Maciejewicz J, Mirek-Bryniarska E, Piotrowski W, Smielak-Korombel W, Tracz W. Kardiol Pol; 2009 Dec; 67(12):1353-9. PubMed ID: 20054766 [Abstract] [Full Text] [Related]
3. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. EUROASPIRE II Study Group. Eur Heart J; 2001 Apr; 22(7):554-72. PubMed ID: 11259143 [Abstract] [Full Text] [Related]
8. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U, EUROASPIRE Study Group. Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307 [Abstract] [Full Text] [Related]
9. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study). Reiner Z, Mihatov S, Milicić D, Bergovec M, Planinc D, TASPIC-CRO Study Group Investigators. Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158 [Abstract] [Full Text] [Related]
10. [Secondary prevention of coronary disease in France. Result of the EUROASPIRE study: the Lille register of ischemic cardiopathies]. Montaye M, Richard F, Lemaire B, Domanievitcz RM, Lenoir MF, Danet S, Amouyel P. Arch Mal Coeur Vaiss; 1998 Oct; 91(10):1211-20. PubMed ID: 9833084 [Abstract] [Full Text] [Related]
11. [Secondary prevention of coronary heart disease. Results from EuroASPIRE I and II in the region of Münster, Germany]. Heidrich J, Liese AD, Kalic M, Winter-Enbergs A, Wellmann J, Roeder N, Kerber S, Breithardt G, Scheld HH, Kleine-Katthöfer P, Keil U. Dtsch Med Wochenschr; 2002 Mar 29; 127(13):667-72. PubMed ID: 11928058 [Abstract] [Full Text] [Related]
13. Computerised systematic secondary prevention in ischaemic heart disease: a study in one practice. Starkey C, Michaelis J, de Lusignan S. Public Health; 2000 May 29; 114(3):169-75. PubMed ID: 10878743 [Abstract] [Full Text] [Related]
16. Cardiovascular risk factors in the Lublin Region population with and without type-2 diabetes mellitus. Mardarowicz G, Lopatyński J, Szcześniak G. Ann Univ Mariae Curie Sklodowska Med; 2003 May 29; 58(2):471-7. PubMed ID: 15323239 [Abstract] [Full Text] [Related]